Moreover, RANK gene expression was higher in hormone receptor-negative tumor samples (p < 0.001) while RANKL showed the opposite trend (Fig. 2a) confirming previous findings [12, 34]. This evidence concerns the gene TNFRSF11A and neoplasm.